(E)-15-(N-4-Bromo-1-naphthyl)sophoridinic imine

Names and Identifiers

Canonical SMILES: Brc1ccc(/N=C2\CCC[C@@H]3[C@H]4CCCN5CCC[C@H](CN23)[C@@H]45)c2ccccc12

Standard InChI: InChI=1S/C25H30BrN3/c26-21-12-13-22(19-8-2-1-7-18(19)21)27-24-11-3-10-23-20-9-5-15-28-14-4-6-17(25(20)28)16-29(23)24/h1-2,7-8,12-13,17,20,23,25H,3-6,9-11,14-16H2/b27-24+/t17-,20-,23-,25+/m1/s1

Standard InChI Key: UETHRKWPGIPNOD-RSLQCYLQSA-N

Molfile:

     RDKit          2D

 33 38  0  0  0  0  0  0  0  0999 V2000
   20.1202  -24.0452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1202  -24.8624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8255  -25.2669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5273  -24.8624    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2294  -25.2717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9394  -24.8684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9429  -24.0512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8255  -23.6325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5290  -24.0482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2369  -23.6490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8298  -22.8176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5439  -22.4168    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2497  -22.8360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9617  -22.4365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9740  -21.6163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2682  -21.1972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5500  -21.5982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8468  -21.1819    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5235  -23.2280    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   22.2293  -24.4662    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   22.9515  -23.2446    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   20.8177  -24.4497    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   20.8557  -20.3648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5696  -19.9670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5788  -19.1506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8751  -18.7335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1548  -19.9538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1622  -19.1414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4634  -18.7306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7567  -19.1311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7533  -19.9467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4527  -20.3538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8814  -17.9164    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  8  1  0
  2  3  1  0
  3  4  1  0
  9  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7 10  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 10 13  1  0
 12 11  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
  9 19  1  6
 10 20  1  6
 13 21  1  1
  8 22  1  1
 18 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 28  1  0
 27 23  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 27  2  0
 26 33  1  0
M  END

Alternative Forms

Parent:

ALA4238594
---

Associated Targets(Human)

HepG2 (196354 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

HeLa (62764 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Associated Targets(non-human)

Topoisomerase I (119 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Molecule Features

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Small molecule	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Drug Indications

MESH ID	MESH Heading	EFO IDs	EFO Terms	Max Phase for Indication	References

Mechanisms of Action

Mechanism of Action	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	References

Calculated Properties

Molecular Weight: 452.44	Molecular Weight (Monoisotopic): 451.1623	AlogP: 5.99	#Rotatable Bonds: 1
Polar Surface Area: 18.84	Molecular Species: BASE	HBA: 2	HBD: ┄
#RO5 Violations: 1	HBA (Lipinski): 3	HBD (Lipinski): ┄	#RO5 Violations (Lipinski): 1
CX Acidic pKa: ┄	CX Basic pKa: 8.79	CX LogP: 5.05	CX LogD: 3.27
Aromatic Rings: 2	Heavy Atoms: 29	QED Weighted: 0.53	Np Likeness Score: 0.18

References

1. Xu Y, Jing D, Chen R, Rashid HU, Jiang J, Liu X, Wang L, Xie P.. (2018) Design, synthesis and evaluation of novel sophoridinic imine derivatives containing conjugated planar structure as potent anticancer agents., 26 (14): [PMID:30007563] [10.1016/j.bmc.2018.07.001]

Source

Source(1):

Scientific Literature